BRIEF-Galapagos picks pre-clinical candidate cachexia drug - Forbes
BRIEF-Galapagos picks pre-clinical candidate cachexia drug - Forbes
* Galapagos said it has selected a pre-clinical candidate drug for its cachexia program, or loss of weight and muscle mass program * Said the candidate drug, G1001092, is a small molecule that Galapagos has developed and which has shown promise in …
